| National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen–based screening MW Drazer, D Huo, SE Eggener Journal of Clinical Oncology 33 (22), 2416-2423, 2015 | 228 | 2015 |
| Global trends in testicular cancer incidence and mortality A Rosen, G Jayram, M Drazer, SE Eggener European urology 60 (2), 374-379, 2011 | 172 | 2011 |
| How I diagnose and manage individuals at risk for inherited myeloid malignancies JECLAG The University of Chicago Hematopoietic Malignancies Cancer Risk Team ... Blood, blood-2016-05-670240, 2016 | 151* | 2016 |
| Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States MW Drazer, D Huo, MA Schonberg, A Razmaria, SE Eggener Journal of Clinical Oncology 29 (13), 1736, 2011 | 118 | 2011 |
| Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies MW Drazer, S Kadri, M Sukhanova, SA Patil, AH West, S Feurstein, ... Blood advances 2 (2), 146-150, 2018 | 109 | 2018 |
| Genetic predisposition to leukemia and other hematologic malignancies S Feurstein, MW Drazer, LA Godley Seminars in Oncology 43 (5), 598-608, 2016 | 77 | 2016 |
| National trends in prostate cancer screening among older American men with limited 9‐year life expectancies: evidence of an increased need for shared decision making MW Drazer, SM Prasad, D Huo, MA Schonberg, W Dale, RZ Szmulewitz, ... Cancer 120 (10), 1491-1498, 2014 | 71 | 2014 |
| 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates SM Prasad, MW Drazer, D Huo, JC Hu, SE Eggener Jama 307 (16), 1692-1694, 2012 | 69 | 2012 |
| Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet? K Tawana, MW Drazer, JE Churpek Leukemia 32 (7), 1482-1492, 2018 | 66 | 2018 |
| Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages S Feurstein, AM Trottier, N Estrada-Merly, M Pozsgai, K McNeely, ... Blood, The Journal of the American Society of Hematology 140 (24), 2533-2548, 2022 | 53 | 2022 |
| Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes MF Walsh, DI Ritter, C Kesserwan, D Sonkin, D Chakravarty, E Chao, ... Human mutation 39 (11), 1542-1552, 2018 | 49 | 2018 |
| Analysis of impact of post-treatment biopsies in phase I clinical trials RF Sweis, MW Drazer, MJ Ratain Journal of Clinical Oncology 34 (4), 369, 2016 | 37 | 2016 |
| Light chain C‐terminal region reinforces the stability of clathrin heavy chain trimers JA Ybe, S Perez‐Miller, Q Niu, DA Coates, MW Drazer, ME Clegg Traffic 8 (8), 1101-1110, 2007 | 37 | 2007 |
| The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy CC Homan, SL King-Smith, DM Lawrence, P Arts, J Feng, J Andrews, ... Haematologica 106 (11), 3004, 2021 | 31 | 2021 |
| Inherited susceptibility to hematopoietic malignancies in the era of precision oncology GW Roloff, MW Drazer, LA Godley JCO Precision Oncology 5, 107-122, 2021 | 29 | 2021 |
| Hereditary myelodysplastic syndrome and acute myeloid leukemia: diagnosis, questions, and controversies IJ Akpan, AEG Osman, MW Drazer, LA Godley Current Hematologic Malignancy Reports 13, 426-434, 2018 | 27 | 2018 |
| Germline predisposition to hematopoietic malignancies S Feurstein, M Drazer, LA Godley Human molecular genetics 30 (R2), R225-R235, 2021 | 23 | 2021 |
| Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies GW Roloff, LA Godley, MW Drazer Genetics in Medicine 23 (1), 211-214, 2021 | 22 | 2021 |
| Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy AA Patel, AE Rojek, MW Drazer, H Weiner, LA Godley, MM Le Beau, ... Blood Advances 5 (20), 4140-4148, 2021 | 17 | 2021 |
| Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model S Borst, CC Nations, JG Klein, G Pavani, JA Maguire, RM Camire, ... Stem Cell Reports 16 (6), 1458-1467, 2021 | 16 | 2021 |
Scott EggenerProfessor of Surgery (Urologic Oncology), University of ChicagoVerified email at surgery.bsd.uchicago.edu
